Adcock cashes in on SA’s flu bug

PUBLISHED: Wed, 21 Feb 2018 11:26:44 GMT
Share

JSE listed pharmaceutical company Adcock Ingram Group delivered interim results for six-months ended 31 December 2017 today, with an increase in headline earnings per share.

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.